1-9 of 9
Byoung S. Kwon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB090: IL-18 secreting chimeric antigen receptor T cells targeting glypican-3show superior persistence and antitumor immunity against hepatocellular carcinoma

Joseph H. Jeong, Young-Kyun Chang, You-Yeon Kang, Jeong-Yun Lee, Sae-Rom Lee, Yun-Kyung Lee, Young-Ho Kim, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): LB090.
https://doi.org/10.1158/1538-7445.AM2023-LB090
Published: 14 April 2023
View article titled, Abstract LB090: IL-18 secreting chimeric antigen receptor T cells targeting glypican-3show superior persistence and antitumor immunity against hepatocellular carcinoma
Journal Articles

Abstract LB176: Anti-4-1BB x PD-1, a bispecific anti-cancer therapeutics

Byoung S. Kwon, Hanna Lee, Jin Sung Park, Yeonji Oh, SeungHee Han, Jin Kyung Choi, Bora Hwang, Sun Woo Im, Seunghyun Lee, HoonSung Jeh
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB176.
https://doi.org/10.1158/1538-7445.AM2021-LB176
Published: 01 July 2021
View article titled, Abstract LB176: Anti-4-1BB x PD-1, a bispecific anti-cancer therapeutics
Journal Articles

Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases

Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, Bumseok Kim, Soon B. Hwang, HoonSung Jeh
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB075.
https://doi.org/10.1158/1538-7445.AM2021-LB075
Published: 01 July 2021
View article titled, Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases
Journal Articles

Abstract 3268: Anti-tumor effect of VSIG4 in conversion of immunosuppressive type II macrophage via repolarization

Hye Jeong Kim, Sunhee Hwang, Seung-Hyun Lee, HyunTae Son, Joong Won Lee, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3268.
https://doi.org/10.1158/1538-7445.AM2020-3268
Published: 15 August 2020
View article titled, Abstract 3268: Anti-tumor effect of VSIG4 in conversion of immunosuppressive type II macrophage <em>via</em> repolarization
Journal Articles

Abstract 3235: Activation-inducible TNFR family receptor (AITR) signaling mediates the polarization of CD4+ T cells into Th1, Th2, and Th17, converts Treg to Teff and eradicates solid tumors

Byoung S. Kwon, Seung J. Lee, Young H. Kim, Joong W. Lee, Sun H. Hwang, Dass S. Vinay
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3235.
https://doi.org/10.1158/1538-7445.AM2019-3235
Published: 01 July 2019
View article titled, Abstract 3235: Activation-inducible TNFR family receptor (AITR) signaling mediates the polarization of CD4<sup>+</sup> T cells into Th1, Th2, and Th17, converts Treg to Teff and eradicates solid tumors
Journal Articles

Abstract 3563: Impact of the affinity of chimeric antigen receptor on immune activation profiles of T cells

Chungyong Han, Seon-Hee Kim, Beom K. Choi, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3563.
https://doi.org/10.1158/1538-7445.AM2018-3563
Published: 01 July 2018
View article titled, Abstract 3563: Impact of the affinity of chimeric antigen receptor on immune activation profiles of T cells
Journal Articles

Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand

Sang W. Kang, Sang C. Lee, So H. Park, Juyang Kim, Hyeon H. Kim, Hyeon-Woo Lee, Su K. Seo, Byoung S. Kwon, Hong R. Cho, Byungsuk Kwon
Journal: Cancer Research
Cancer Res (2017) 77 (21): 5989–6000.
https://doi.org/10.1158/0008-5472.CAN-17-0610
Published: 31 October 2017
View article titled, Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand
Open the PDF for Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand in another window
Includes: Supplementary data
Journal Articles

Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity

Young H. Kim, Beom K. Choi, Kwang H. Kim, Sang W. Kang, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2008) 68 (18): 7264–7269.
https://doi.org/10.1158/0008-5472.CAN-08-1365
Published: 14 September 2008
View article titled, Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity
Open the PDF for Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity in another window
Includes: Supplementary data
Journal Articles

Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy

Beom K. Choi, Young H. Kim, Woo J. Kang, Sun K. Lee, Kwang H. Kim, Su M. Shin, Wayne M. Yokoyama, Tae Y. Kim, Byoung S. Kwon
Journal: Cancer Research
Cancer Res (2007) 67 (18): 8891–8899.
https://doi.org/10.1158/0008-5472.CAN-07-1056
Published: 17 September 2007
View article titled, Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy
Open the PDF for Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy in another window
Includes: Supplementary data